Your browser doesn't support javascript.
loading
MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer.
Dinami, Roberto; Pompili, Luca; Petti, Eleonora; Porru, Manuela; D'Angelo, Carmen; Di Vito, Serena; Rizzo, Angela; Campani, Virginia; De Rosa, Giuseppe; Bruna, Alejandra; Serra, Violeta; Mano, Miguel; Giacca, Mauro; Leonetti, Carlo; Ciliberto, Gennaro; Tarsounas, Madalena; Stoppacciaro, Antonella; Schoeftner, Stefan; Biroccio, Annamaria.
Afiliación
  • Dinami R; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
  • Pompili L; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
  • Petti E; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
  • Porru M; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
  • D'Angelo C; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
  • Di Vito S; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
  • Rizzo A; Department of Ecological and Biological Sciences (DEB), University of Tuscia, Viterbo, Italy.
  • Campani V; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
  • De Rosa G; Department of Pharmacy, University Federico II of Naples, Naples, Italy.
  • Bruna A; Department of Pharmacy, University Federico II of Naples, Naples, Italy.
  • Serra V; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Mano M; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Giacca M; Functional Genomics and RNA-based Therapeutics Laboratory, Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.
  • Leonetti C; Department of Life Sciences, University of Coimbra, Coimbra, Portugal.
  • Ciliberto G; King's College London, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, London, UK.
  • Tarsounas M; King's College London, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, London, UK.
  • Stoppacciaro A; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
  • Schoeftner S; Scientific Direction, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
  • Biroccio A; Department of Oncology, Genome Stability and Tumourigenesis Group, MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
EMBO Mol Med ; 15(1): e16033, 2023 01 11.
Article en En | MEDLINE | ID: mdl-36426578
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: MicroARNs / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: MicroARNs / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: Italia